| ★ | STOP-HS: Povorcitinib Shows Durable Response in HS at Week 54 | | 60 | Estados Unidos | |
| 3 | Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata | | 611 | Estados Unidos | 62 |
| 9 | Diabetes Technology at a Turning Point: What’s New and What’s Next | | 581 | Estados Unidos | 60 |
| 4 | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 62 |
| 1 | Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD | | 172 | Estados Unidos | 67 |
| 16 | New AI Model Outperforms Standard Echocardiograms in Heart Disease Detection | | 124 | Estados Unidos | 59 |
| 13 | Lonvo-z at EAACI: Secondary Data & QoL Findings in HAE | Aleena Banerji, MD | | 91 | Estados Unidos | 60 |
| 11 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 60 |
| 15 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 60 |
| 18 | CAPTAIN-T2D: Interim Results Display High Cortisol Prevalence in Difficult-to-Control T2D | | 47 | Estados Unidos | 59 |
| 2 | POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP | | 35 | Estados Unidos | 65 |
| 7 | Non-Sesame Seed and Spice Allergies Can Trigger Severe Reactions | | 35 | Estados Unidos | 61 |
| 17 | HPA-Axis Assessment Allows for Improved Corticosteroid Response Analysis | | 32 | Estados Unidos | 59 |
| 8 | APPs Uniquely Positioned in ILD Collaborative Care | | 31 | Estados Unidos | 61 |
| 5 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 62 |
| 19 | How Environmental Triggers Impact Skin Disease, With Hannah Rodriguez, MPAS, PA-C | | 30 | Estados Unidos | 58 |
| 14 | ALA: Why COVID-19 Boosters Matter Now, With Juanita Mora, MD | | 28 | Estados Unidos | 60 |
| 6 | Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD | | 20 | Estados Unidos | 61 |
| 20 | Discussing Nutrition's Role in Psoriasis Management, With Rajani Katta, MD | | 17 | Estados Unidos | 58 |
| 10 | Key Diagnostic and Therapeutic Pearls for Connective Tissue Disease, With Michelle Min, MD | | 8 | Estados Unidos | 60 |
| 12 | Alternative Endpoints for and Approaches to Metabolic Health, With Daria Igudesman, PhD, MS | | 5 | Estados Unidos | 60 |